Molecular Insights and Emerging Strategies for Treatment of Metastatic Uveal Melanoma

SIMPLE SUMMARY: Around 50% of patients with uveal melanoma (UM) still develop metastatic disease. Despite recent advances in the diagnosis and prognosis of UM, improvements in overall survival have not been achieved. At present, there is no available standard of care for adjuvant and metastatic sett...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallone, Fabiana, Sacchetti, Marta, Lambiase, Alessandro, Moramarco, Antonietta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600598/
https://www.ncbi.nlm.nih.gov/pubmed/32992823
http://dx.doi.org/10.3390/cancers12102761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600598/
https://www.ncbi.nlm.nih.gov/pubmed/32992823
http://dx.doi.org/10.3390/cancers12102761

Ejemplares similares